ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.00% | 22.15% | 17.95% | 15.74% | 25.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.00% | 22.15% | 17.95% | 15.74% | 25.57% |
| Cost of Revenue | 32.06% | 28.02% | 47.09% | 44.32% | 13.45% |
| Gross Profit | 25.19% | 21.36% | 13.86% | 11.73% | 27.42% |
| SG&A Expenses | 5.10% | 1.88% | 8.03% | 6.01% | -14.39% |
| Depreciation & Amortization | -3.75% | -6.69% | 110.40% | 106.45% | 89.59% |
| Other Operating Expenses | 6.52% | 3.27% | -30.92% | -32.21% | 362.97% |
| Total Operating Expenses | 5.28% | 2.06% | 8.70% | 6.66% | 2.45% |
| Operating Income | 5.48% | 8.37% | -3.90% | -1.95% | 6.49% |
| Income Before Tax | -10.97% | -7.58% | -16.70% | -14.52% | -14.81% |
| Income Tax Expenses | 27.78% | 24.32% | 11.63% | 9.30% | -44.62% |
| Earnings from Continuing Operations | -10.99% | -7.60% | -16.70% | -14.51% | -14.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.99% | -7.60% | -16.70% | -14.51% | -14.68% |
| EBIT | 5.48% | 8.37% | -3.90% | -1.95% | 6.49% |
| EBITDA | 5.89% | 8.76% | -4.15% | 0.87% | 16.46% |
| EPS Basic | -11.11% | -11.11% | -18.75% | -18.75% | -12.50% |
| Normalized Basic EPS | -9.09% | 0.00% | -20.00% | -20.00% | 8.33% |
| EPS Diluted | -11.11% | -11.11% | -18.75% | -18.75% | -12.50% |
| Normalized Diluted EPS | -9.09% | 0.00% | -20.00% | -20.00% | 8.33% |
| Average Basic Shares Outstanding | 0.53% | 0.53% | -0.40% | -0.40% | 0.15% |
| Average Diluted Shares Outstanding | 0.53% | 0.53% | -0.40% | -0.40% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |